<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Current Report Filed Pursuant to Section
13 or 15(d) of</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Date of Report</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Date of earliest event reported): June
13, 2012</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Repros
Therapeutics Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 6pt; padding-left: 6pt; font-size: 10pt; font-weight: bold; text-align: center">Delaware</TD>
    <TD STYLE="width: 33%; padding-right: 6pt; padding-left: 6pt; font-size: 10pt; font-weight: bold; text-align: center">001-15281</TD>
    <TD STYLE="width: 33%; padding-right: 6pt; padding-left: 6pt; font-size: 10pt; font-weight: bold; text-align: center">76-0233274</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt; font-weight: bold; text-align: center">(State or other jurisdiction of <BR>
incorporation or organization)</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt; font-weight: bold; text-align: center">(Commission File Number)</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt; font-weight: bold; text-align: center">(I.R.S. Employer Identification No.)</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="padding-right: 6pt; padding-left: 6pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2408 Timberloch Place, Suite B-7</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The Woodlands, Texas 77380</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of principal</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>executive offices</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and zip code)</B></P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 6pt; padding-bottom: 12pt; padding-left: 6pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(281) 719-3400</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Registrant&rsquo;s telephone number,
        including area code)</B></P></TD>
    <TD STYLE="padding-right: 6pt; padding-left: 6pt; font-size: 10pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2 below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#9;Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#9;Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#9;Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#9;Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B></B></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.07&nbsp;&nbsp;Submission of Matters
to a Vote of Security Holders.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.55in">Repros Therapeutics
Inc. (the &ldquo;Company&rdquo;) held its 2012 Annual Meeting of Stockholders (the &ldquo;Meeting&rdquo;) on June 13, 2012 in The
Woodlands, Texas.&nbsp;&nbsp;At the Meeting, the Company&rsquo;s stockholders: (i) elected each of the six persons listed below
under Proposal 1 to serve as a director of the Company until its 2013 Annual Meeting of Stockholders; and (ii) ratified and approved
the appointment of PricewaterhouseCoopers LLP as the Company's registered independent public accounting firm for the Company's
fiscal year ending December 31, 2012. The following table describes the results of the voting at the Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 31%; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Proposal or Name of Nominee</TD>
    <TD STYLE="width: 17%; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Shares Voted<BR>
 &quot;For&quot;</TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Shares Voted<BR>
 &quot;Against&quot;</TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Shares <BR>
Withheld</TD>
    <TD STYLE="width: 14%; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Shares <BR>
Abstained</TD>
    <TD STYLE="width: 10%; border-bottom: black 1pt solid; font-weight: bold; text-align: center">Broker<BR>
 Non-Votes</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify">Proposal 1: Election of Directors</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: justify">&nbsp; Joseph S. Podolski</TD>
    <TD STYLE="text-align: center">6,148,590</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">124,334</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">5,283,098</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp; Daniel F. Cain</TD>
    <TD STYLE="text-align: center">5,594,321</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">678,603</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">5,283,098</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: justify">&nbsp; Jean L. Fourcroy, M.D.,&nbsp;&nbsp; Ph.D.</TD>
    <TD STYLE="text-align: center">5,799,920</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">473,004</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">5,283,098</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp; Nola Masterson, M.S.</TD>
    <TD STYLE="text-align: center">5,594,337</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">678,587</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">5,283,098</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD STYLE="text-align: justify">&nbsp; Jaye Thompson, Ph.D.</TD>
    <TD STYLE="text-align: center">5,960,966</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">311,958</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">5,283,098</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="text-align: justify">&nbsp; Michael G. Wyllie, Ph.D., DSC</TD>
    <TD STYLE="text-align: center">5,804,429</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">468,495</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">5,283,098</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,255,204)">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD>Proposal 2: Ratification of Appointment of PricewaterhouseCoopers LLP</TD>
    <TD STYLE="text-align: center">11,338,584</TD>
    <TD STYLE="text-align: center">212,823</TD>
    <TD STYLE="text-align: center">--</TD>
    <TD STYLE="text-align: center">4,615</TD>
    <TD STYLE="text-align: center">--</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: left; width: 50%">&nbsp;</TD><TD STYLE="text-align: right; width: 50%"></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-variant: small-caps"><B>Repros Therapeutics Inc.</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">Date:
June 14, 2012</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Joseph S. Podolski</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Joseph S. Podolski<BR>President and Chief Executive Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v316134_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 16265}]
{"company-data": {"conformed-name": "REPROS THERAPEUTICS INC.", "cik": "0000897075", "assigned-sic": "2836", "irs-number": "760233274", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-15281", "film-number": "12908070"}, "business-address": {"street1": "2408 TIMBERLOCH PL", "street2": "SUITE B-7", "city": "WOODLANDS", "state": "TX", "zip": "77380", "phone": "2817193400"}, "mail-address": {"street1": "2408 TIMBERLOCH PLACE B-7", "city": "THE WOODLANDS", "state": "TX", "zip": "77380"}, "former-company": [{"former-conformed-name": "REPROS THERAPEUTICS INC", "date-changed": "20060503"}, {"former-conformed-name": "ZONAGEN INC", "date-changed": "19930208"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Filed Pursuant to Section
13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): June
13, 2012
Repros
Therapeutics Inc.
(Exact name of registrant as specified
in its charter)
Delaware
001-15281
76-0233274
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
2408 Timberloch Place, Suite B-7
The Woodlands, Texas 77380
(Address of principal
executive offices
and zip code)
(281) 719-3400
(Registrant's telephone number,
        including area code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2 below):
¨
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)
Item 5.07  Submission of Matters
to a Vote of Security Holders.
Repros Therapeutics
Inc. (the "Company") held its 2012 Annual Meeting of Stockholders (the "Meeting") on June 13, 2012 in The
Woodlands, Texas.  At the Meeting, the Company's stockholders: (i) elected each of the six persons listed below
under Proposal 1 to serve as a director of the Company until its 2013 Annual Meeting of Stockholders; and (ii) ratified and approved
the appointment of PricewaterhouseCoopers LLP as the Company's registered independent public accounting firm for the Company's
fiscal year ending December 31, 2012. The following table describes the results of the voting at the Meeting:
Proposal or Name of Nominee
Shares Voted
"For"
Shares Voted
"Against"
Shares
Withheld
Shares
Abstained
Broker
Non-Votes
Proposal 1: Election of Directors
Joseph S. Podolski
6,148,590
--
124,334
--
5,283,098
Daniel F. Cain
5,594,321
--
678,603
--
5,283,098
Jean L. Fourcroy, M.D.,   Ph.D.
5,799,920
--
473,004
--
5,283,098
Nola Masterson, M.S.
5,594,337
--
678,587
--
5,283,098
Jaye Thompson, Ph.D.
5,960,966
--
311,958
--
5,283,098
Michael G. Wyllie, Ph.D., DSC
5,804,429
--
468,495
--
5,283,098
Proposal 2: Ratification of Appointment of PricewaterhouseCoopers LLP
11,338,584
212,823
--
4,615
--
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Repros Therapeutics Inc.
Date:
June 14, 2012
By:
/s/ Joseph S. Podolski
Joseph S. Podolski
President and Chief Executive Officer